Exact Mass: 277.27693500000004

Exact Mass Matches: 277.27693500000004

Found 15 metabolites which its exact mass value is equals to given mass value 277.27693500000004, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Perhexiline

(-)-2-(2,2-Dicyclohexylethyl)piperidine

C19H35N (277.27693500000004)


Perhexiline is only found in individuals that have used or taken this drug. It is a coronary vasodilator used especially for angina of effort. It may cause neuropathy and hepatitis. [PubChem]Perhexiline binds to the mitochondrial enzyme carnitine palmitoyltransferase (CPT)-1 and CPT-2. It acts by shifting myocardial substrate utilisation from long chain fatty acids to carbohydrates through inhibition of CPT-1 and, to a lesser extent, CPT-2, resulting in increased glucose and lactate utilization. This results in increased ATP production for the same O2 consumption as before and consequently increases myocardial efficiency. C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C - Cardiovascular system > C08 - Calcium channel blockers > C08E - Non-selective calcium channel blockers D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   
   

2-(5-Hexenyl)-3,4-dihydro-5-nonyl-2H-pyrrole

2-(5-Hexenyl)-3,4-dihydro-5-nonyl-2H-pyrrole

C19H35N (277.27693500000004)


   
   

2-Hex-5-enyl-5-non-8-enyl-pyrrolidine

2-Hex-5-enyl-5-non-8-enyl-pyrrolidine

C19H35N (277.27693500000004)


   

(2R,5R)-2-(pent-4-en-1-yl)-5-pentyldecahydroquinoline

(2R,5R)-2-(pent-4-en-1-yl)-5-pentyldecahydroquinoline

C19H35N (277.27693500000004)


   

(5R,6R,8R,8aR)-6,8-dimethyl-5-(non-8-en-1-yl)octahydroindolizine

(5R,6R,8R,8aR)-6,8-dimethyl-5-(non-8-en-1-yl)octahydroindolizine

C19H35N (277.27693500000004)


   

1-methyl-4-(non-8-en-1-yl)octahydro-2H-quinolizine

1-methyl-4-(non-8-en-1-yl)octahydro-2H-quinolizine

C19H35N (277.27693500000004)


   

(3R,5S)-5-methyl-3-(non-8-en-1-yl)octahydro-1H-pyrrolo[1,2-a]azepine

(3R,5S)-5-methyl-3-(non-8-en-1-yl)octahydro-1H-pyrrolo[1,2-a]azepine

C19H35N (277.27693500000004)


   

PERHEXILINE

PERHEXILINE

C19H35N (277.27693500000004)


C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker C - Cardiovascular system > C08 - Calcium channel blockers > C08E - Non-selective calcium channel blockers D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker

   

(3r,5r,9ar)-5-methyl-3-(non-8-en-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

(3r,5r,9ar)-5-methyl-3-(non-8-en-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

C19H35N (277.27693500000004)


   

2-(hex-1-en-1-yl)-5-nonyl-4,5-dihydro-1h-pyrrole

2-(hex-1-en-1-yl)-5-nonyl-4,5-dihydro-1h-pyrrole

C19H35N (277.27693500000004)


   

5-methyl-3-(non-8-en-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

5-methyl-3-(non-8-en-1-yl)-octahydro-1h-pyrrolo[1,2-a]azepine

C19H35N (277.27693500000004)


   

2-(hex-1-en-1-yl)-5-nonylidenepyrrolidine

2-(hex-1-en-1-yl)-5-nonylidenepyrrolidine

C19H35N (277.27693500000004)


   

(2s,5s)-2-(hex-5-en-1-yl)-5-(non-8-en-1-yl)pyrrolidine

(2s,5s)-2-(hex-5-en-1-yl)-5-(non-8-en-1-yl)pyrrolidine

C19H35N (277.27693500000004)